Searchable abstracts of presentations at key conferences in endocrinology

ea0090p384 | Endocrine-related Cancer | ECE2023

Impact of SSTR PET/CT imaging on the follow-up of pancreatic NET in MEN1

Kostiainen Iiro , Majala Susanna , Schildt Jukka , Parviainen Helka , Kauhanen Saila , Seppanen Hanna , Miettinen Paivi , Matikainen Niina , Ryhanen Eeva , Schalin-Jantti Camilla

Introduction: In multiple endocrine neoplasia 1 (MEN1), the decreased life expectancy is related especially to pancreatic neuroendocrine tumors (panNETs). Timely diagnosis of potentially aggressive panNETs is the cornerstone of the follow-up in MEN1. Somatostatin receptor positron emission tomography (SSTR PET/CT) has a high accuracy in the detection of neuroendocrine tumors. The role of this imaging modality in early diagnosis and follow-up of MEN1-related panNETs is unclear....

ea0056p117 | Endocrine tumours and neoplasia | ECE2018

Adrenocortical carcinoma – characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years

Kostiainen Iiro , Hakaste Liisa , Kejo Pekka , Parviainen Helka , Laine Tiina , Pennanen Mirkka , Arola Johanna , Haglund Caj , Heiskanen Ilkka , Schalin-Jantti Camilla

Background: Adrenal cortical carcinoma (ACC) is a rare malignancy known to be highly aggressive, with few specific treatment options. The objective was to evaluate clinicopathological features and outcome in patients treated at Helsinki University HospitalMethods and patients: We included all patients diagnosed with adrenocortical carcinoma (Weiss score ≥4) at Helsinki University Hospital during the years 2002 through 2017. Patients were identified...

ea0073pep9.5 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Endothelial and vascular function, biomarkers and clinical presentation in patients with small intestine NETs

Kostiainen Iiro , Rosengård-Bärlund Milla , Karppinen Noora , Simonen Piia , Rapola Janne , Lindén Riikka , Schalin-Jäntti Camilla , Matikainen Niina

Background20–30% of patients with metastatic small intestine neuroendocrine tumours (SI-NETs) suffer from carcinoid syndrome (CS), i.e. diarrhea, flushing, and bronchospasm. Of these, 25–50% develop carcinoid heart disease (CHD) characterized by valve fibrosis and right heart failure. There are no early predictive markers of CHD, which typically is diagnosed in the advanced stage.Aims of the studyTo...